Review Article
Microorganisms in the Treatment of Cancer: Advantages and Limitations
Table 1
A representative list of microorganisms used/planned to be used in anticancer therapy.
| Microorganism | Strain/antigen | Cancer | Type of treatment | Deployment |
| Mycobacterium bovis | Atenuated strain Calmette-Guérin | Superficial bladder cancer | Complementary therapy | Commonly used | Streptococcus pyogenes | OK-432 | Lymphangioma | Alternative therapy for surgical treatment | Commonly used | Clostridium novyi | Strain NT | Solid tumors | No data | Clinical trials | Salmonella enterica serovar Typhimurium | Strain VNP20009 | Melanoma | No data | Clinical trials | Magnetococcus marinus | MC1 | Solid tumors and some metabolic tumors | Additional therapy supporting chemotherapy | Experimental research (animal studies) | Toxoplasma gondii | CPS/TLA | Pancreas, lung and ovarian cancer, and melanoma | No data | Experimental research | Plasmodium falciparum | rVAR2-DT | Melanoma expressing CS | No data | Experimental research |
|
|